Medicine by Design's $4-million Pivotal Experiment Fund aims to bridge one of the critical gaps in the “valley of death” between a research discovery and a translatable therapy.
Panel of Canadian regenerative medicine leaders tackle translation and commercialization challenges in panel discussion
How do trainees get started on a path toward developing a product or starting a company? What steps do researchers need to take to move their regenerative medicine discoveries from the lab toward clinical impact? These are just some of the questions an expert panel tackled on July 30 at a virtual event titled Translating Research to Impact – Leveraging Our Ecosystem.
Weekly webinar series for trainees to cover key concepts in translation and commercialization of regenerative medicine.
The competition was the culmination of Medicine by Design’s “Pitching Science” workshop, a six-week long program for graduate students, post-doctoral fellows and research associates
Medicine by Design and Creative Destruction Lab partner to accelerate the commercialization of world-class research in regenerative medicine
Organizations collaborating to launch a health-themed cohort at CDL-Toronto to help technical teams take their health innovations to market by providing access to accomplished mentors and investors in life sciences.
"Toronto really is a unique place to pursue regenerative medicine research."
This month-long series of workshops, lab sessions, tours and conferences aims to advance knowledge and skills required to commercialize new therapies.